drugset / Trial / NCT05213832

Effect of Inhalatory Sedation in Subarachnoid Hemorrhage

NCT05213832

Phase 2 Completed 11 enrolled A.O.U. Città della Salute e della Scienza
NaSingle-groupOpen-labelSupportive care

Summary

The aim of this study is to evaluate the effect of inhalational sedation on cerebral perfusion in patients with SAH. It will evaluate whether the administration of isofluorane, by inducing direct vasodilation in the cerebral parenchyma, can improve the cerebral perfusion rates. Perfusional CT will be used to study the variation of cerebral blood flow to rule out the vasodilatory effect on territories with different cerebrovascular reactivity aggravating the phenomena of distrectual hypoperfusion (theft theory).

Timeline

Start
2020-06-26
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified Inhaled